PULMONX CORPORATION Operating Expenses
PULMONX CORPORATION (LUNG) reported Operating Expenses of $26.80 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-04
- PULMONX CORPORATION operating expenses for the quarter ending 2026-06-30 was $26.80M, a 16.27% decline year-over-year.
- PULMONX CORPORATION operating expenses for the quarter ending 2026-03-31 was $29.00M, a 6.16% decline year-over-year.
- PULMONX CORPORATION operating expenses for the quarter ending 2025-12-31 was $27.44M, a 11.49% decline year-over-year.
- PULMONX CORPORATION operating expenses for the quarter ending 2025-09-30 was $30.45M, a 4.42% increase year-over-year.
- PULMONX CORPORATION operating expenses for fiscal 2025 was $120.80M, a 0.92% increase from fiscal 2024.
- PULMONX CORPORATION operating expenses for fiscal 2024 was $119.70M, a 6.23% increase from fiscal 2023.
- PULMONX CORPORATION operating expenses for fiscal 2023 was $112.69M, a 14.40% increase from fiscal 2022.
- PULMONX CORPORATION operating expenses for fiscal 2022 was $98.50M, a 18.77% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26.80M 10-Q · filed 2026-08-04 | $55.80M 10-Q · filed 2026-08-04 | $83.24M derived: sum of 3 quarters · filed 2026-08-04 | $113.69M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2026-03-31 | $29.00M 10-Q · filed 2026-05-04 | $56.44M derived: sum of 2 quarters · filed 2026-05-04 | $86.89M derived: sum of 3 quarters · filed 2026-05-04 | $118.90M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-12-31 | $27.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $57.89M derived: sum of 2 quarters · filed 2026-03-10 | $89.90M derived: sum of 3 quarters · filed 2026-08-04 | $120.80M 10-K · filed 2026-03-10 | ||
| 2025-09-30 | $30.45M 10-Q · filed 2025-11-12 | $62.45M derived: sum of 2 quarters · filed 2026-08-04 | $93.36M 10-Q · filed 2025-11-12 | $124.36M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-06-30 | $32.01M 10-Q · filed 2026-08-04 | $62.91M 10-Q · filed 2026-08-04 | $93.92M derived: sum of 3 quarters · filed 2026-08-04 | $123.08M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $30.91M 10-Q · filed 2026-05-04 | $61.91M derived: sum of 2 quarters · filed 2026-05-04 | $91.07M derived: sum of 3 quarters · filed 2026-05-04 | $122.00M derived: sum of 4 quarters · filed 2026-05-04 | ||
| 2024-12-31 | $31.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $60.16M derived: sum of 2 quarters · filed 2026-03-10 | $91.09M derived: sum of 3 quarters · filed 2026-03-10 | $119.70M 10-K · filed 2026-03-10 | ||
| 2024-09-30 | $29.16M 10-Q · filed 2025-11-12 | $60.08M derived: sum of 2 quarters · filed 2025-11-12 | $88.70M 10-Q · filed 2025-11-12 | $117.02M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $30.93M 10-Q · filed 2025-08-01 | $59.54M 10-Q · filed 2025-08-01 | $87.86M derived: sum of 3 quarters · filed 2025-08-01 | $116.07M derived: sum of 4 quarters · filed 2025-08-01 | ||
| 2024-03-31 | $28.61M 10-Q · filed 2025-05-02 | $56.93M derived: sum of 2 quarters · filed 2025-05-02 | $85.14M derived: sum of 3 quarters · filed 2025-05-02 | $114.31M derived: sum of 4 quarters · filed 2025-05-02 | ||
| 2023-12-31 | $28.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $56.52M derived: sum of 2 quarters · filed 2025-02-25 | $85.70M derived: sum of 3 quarters · filed 2025-02-25 | $112.69M 10-K · filed 2025-02-25 | ||
| 2023-09-30 | $28.20M 10-Q · filed 2024-11-01 | $57.38M derived: sum of 2 quarters · filed 2024-11-01 | $84.37M 10-Q · filed 2024-11-01 | $110.18M derived: sum of 4 quarters · filed 2024-11-01 | ||
| 2023-06-30 | $29.17M 10-Q · filed 2024-08-02 | $56.16M 10-Q · filed 2024-08-02 | $81.97M derived: sum of 3 quarters · filed 2024-08-02 | $106.06M derived: sum of 4 quarters · filed 2024-08-02 | ||
| 2023-03-31 | $26.99M 10-Q · filed 2024-05-03 | $52.80M derived: sum of 2 quarters · filed 2024-05-03 | $76.88M derived: sum of 3 quarters · filed 2024-05-03 | $101.71M derived: sum of 4 quarters · filed 2024-05-03 | ||
| 2022-12-31 | $25.81M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $49.89M derived: sum of 2 quarters · filed 2024-02-27 | $74.72M derived: sum of 3 quarters · filed 2024-02-27 | $98.50M 10-K · filed 2024-02-27 | ||
| 2022-09-30 | $24.08M 10-Q · filed 2023-11-03 | $48.91M derived: sum of 2 quarters · filed 2023-11-03 | $72.69M 10-Q · filed 2023-11-03 | $95.31M derived: sum of 4 quarters · filed 2023-11-03 | ||
| 2022-06-30 | $24.83M 10-Q · filed 2023-08-04 | $48.61M 10-Q · filed 2023-08-04 | $71.22M derived: sum of 3 quarters · filed 2023-08-04 | $90.73M derived: sum of 4 quarters · filed 2023-08-04 | ||
| 2022-03-31 | $23.78M 10-Q · filed 2023-05-08 | $46.40M derived: sum of 2 quarters · filed 2023-05-08 | $65.90M derived: sum of 3 quarters · filed 2023-05-08 | $87.61M derived: sum of 4 quarters · filed 2023-05-08 | ||
| 2021-12-31 | $22.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $42.12M derived: sum of 2 quarters · filed 2023-03-01 | $63.83M derived: sum of 3 quarters · filed 2023-03-01 | $82.93M 10-K · filed 2023-03-01 | ||
| 2021-09-30 | $19.50M 10-Q · filed 2022-11-08 | $41.21M derived: sum of 2 quarters · filed 2022-11-08 | $60.32M 10-Q · filed 2022-11-08 | $76.75M derived: sum of 4 quarters · filed 2022-11-08 | ||
| 2021-06-30 | $21.71M 10-Q · filed 2022-08-08 | $21.13M 10-Q · filed 2021-08-10 | $40.82M 10-Q · filed 2022-08-08 | $39.76M 10-Q · filed 2021-08-10 | $57.25M derived: sum of 3 quarters · filed 2022-08-08 | $70.06M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $19.11M 10-Q · filed 2022-05-09 | $18.64M 10-Q · filed 2021-05-12 | $35.54M derived: sum of 2 quarters · filed 2022-05-09 | $48.35M derived: sum of 3 quarters · filed 2022-05-09 | $60.88M derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | $16.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $29.24M derived: sum of 2 quarters · filed 2022-03-01 | $41.78M derived: sum of 3 quarters · filed 2022-03-01 | $53.53M 10-K · filed 2022-03-01 | ||
| 2020-09-30 | $12.81M 10-Q · filed 2021-11-09 | $25.35M derived: sum of 2 quarters · filed 2021-11-09 | $37.10M 10-Q · filed 2021-11-09 | $48.73M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-06-30 | $12.54M 10-Q · filed 2021-08-10 | $24.29M 10-Q · filed 2021-08-10 | $35.92M derived: sum of 3 quarters · filed 2021-08-10 | $45.94M derived: sum of 4 quarters · filed 2021-08-10 | ||
| 2020-03-31 | $11.75M 10-Q · filed 2021-05-12 | $23.38M derived: sum of 2 quarters · filed 2021-05-12 | $33.40M derived: sum of 3 quarters · filed 2021-05-12 | |||
| 2019-12-31 | $11.63M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $21.65M derived: sum of 2 quarters · filed 2021-03-15 | $40.25M 10-K · filed 2021-03-15 | |||
| 2019-09-30 | $10.02M 10-Q · filed 2020-11-13 | $28.63M 10-Q · filed 2020-11-13 | ||||
| 2018-12-31 | $27.34M 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |